- Home
- ARVN vs PLUG Comparison
ARVN vs PLUG Comparison
Compare ARVN & PLUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- PLUG
- Stock Information
- Founded
- ARVN 2015
- PLUG 1997
- Country
- ARVN United States
- PLUG United States
- Employees
- ARVN N/A
- PLUG N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- PLUG Industrial Machinery/Components
- Sector
- ARVN Health Care
- PLUG Energy
- Exchange
- ARVN Nasdaq
- PLUG Nasdaq
- Market Cap
- ARVN 1.7B
- PLUG 1.9B
- IPO Year
- ARVN 2018
- PLUG 1999
- Fundamental
- Price
- ARVN $25.76
- PLUG $2.37
- Analyst Decision
- ARVN Strong Buy
- PLUG Hold
- Analyst Count
- ARVN 15
- PLUG 26
- Target Price
- ARVN $57.50
- PLUG $4.99
- AVG Volume (30 Days)
- ARVN 487.9K
- PLUG 38.4M
- Earning Date
- ARVN 10-30-2024
- PLUG 11-07-2024
- Dividend Yield
- ARVN N/A
- PLUG N/A
- EPS Growth
- ARVN N/A
- PLUG N/A
- EPS
- ARVN N/A
- PLUG N/A
- Revenue
- ARVN $93,300,000.00
- PLUG $684,486,000.00
- Revenue This Year
- ARVN $179.49
- PLUG N/A
- Revenue Next Year
- ARVN N/A
- PLUG $46.28
- P/E Ratio
- ARVN N/A
- PLUG N/A
- Revenue Growth
- ARVN N/A
- PLUG N/A
- 52 Week Low
- ARVN $13.57
- PLUG $1.60
- 52 Week High
- ARVN $53.08
- PLUG $6.96
- Technical
- Relative Strength Index (RSI)
- ARVN 50.68
- PLUG 61.43
- Support Level
- ARVN $25.42
- PLUG $2.01
- Resistance Level
- ARVN $29.24
- PLUG $2.14
- Average True Range (ATR)
- ARVN 1.24
- PLUG 0.13
- MACD
- ARVN 0.18
- PLUG 0.02
- Stochastic Oscillator
- ARVN 34.71
- PLUG 100.00
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About PLUG Plug Power Inc.
Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage, and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets, including material handling, e-mobility, power generation, and industrial applications.